Construction haw begun on a new sterile production plant for the Zoladex cancer drug at AstraZeneca’s Macclesfield campus.
BES, the Rochdale-based specialist in design and delivery of complex pharmaceutical environments, is leading the project which was officially announced during a visit by Prime Minister Boris Johnson.
The company has delivered an array of projects for AstraZeneca over the past 20 years, including a previous sterile production facility for Zoladex in 2016, and a recent global packing centre..
BES is responsible for the fit-out and commissioning of the new plant, which will be completed by the end of 2022.
Taking on the role of principal contractor from May the company is responsible for safety, buildability and CDM (construction design & management) compliance on the project.
Don't miss a thing - sign up for your free North West newsletter - and follow us on LinkedIn
Email newsletters
BusinessLive is your home for business news from around the North West- and you can stay in touch with all the latest news from Greater Manchester, Liverpool City Region, Cheshire, Lancashire and Cumbria through our email alerts.
You can sign up to receive daily morning news bulletins from every region we cover and to weekly email bulletins covering key economic sectors from manufacturing to technology and enterprise. And we'll send out breaking news alerts for any stories we think you can't miss.
Visit our email preference centre to sign up to all the latest news from BusinessLive.
For all the latest stories, views, polls and more - and the news as it breaks - .
Graham Drew, BES project director, said: "The new sterile production facility we are delivering at AstraZeneca’s Macclesfield is a highly complex and process-driven environment, calling upon the specialist expertise of our multi-disciplinary team.
"We are responsible for installation and commissioning of all architectural, HVAC, electrical and process utilities, for the building’s sterile accommodation, associated cleanroom areas and technical spaces.
Most Read
"We will also co-ordinate installation and integration of the client’s process equipment, within the heavily serviced production environment."
Neil Bennion, project manager from AstraZeneca, added: "Continued investment in our production capability for Zoladex is an important part of global cancer treatment preparedness and of our ability to respond to increased demand and support patients worldwide.
"BES’s experience of delivering similar projects for AstraZeneca, their multi-disciplinary team and their technical expertise made them the ideal collaborative partner on this project to help us realise our goals for quality assured and time critical project delivery."